 |
 |
 |
 |
 |
 |
 |
 |
| • |
Available
data do not indicate an increased risk of
|
|
|
|
major
birth defects (first trimester)
|
|
|
| • |
Limited
experience on pregnancy outcomes with
|
|
|
|
prenatal
exposure to valacyclovir or famciclovir
|
|
|
| • |
Acyclovir
may be used with first episode or severe
|
|
|
recurrent
disease
|
|
|
| • |
Risk
of transmission to the neonate is 30-50%
|
|
|
|
among
women who acquire HSV near delivery
|
|